Group One Trading, L.P. 4 D Molecular Therapeutics, Inc. Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$20.93 - $30.01 $43,220 - $61,970	2,065 New	2,065 $43,000
Q4 2023 Feb 14, 2024	BUY	$9.76 - $21.25 $31,876 - $69,402	3,266 Added 768.47%	3,691 $74,000
Q3 2023 Nov 09, 2023	SELL	$12.64 - $19.76 $7,786 - $12,172	-616 Reduced 59.17%	425 $5,000
Q2 2023 Aug 09, 2023	BUY	$15.16 - $23.26 $3,790 - $5,815	250 Added 31.61%	1,041 $18,000
Q1 2023 May 12, 2023	BUY	$15.45 - $23.19 $12,220 - $18,343	791 New	791 $13,000
Q1 2022 May 12, 2022	SELL	$13.16 - $22.64 $3,184 - $5,478	-242 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$19.56 - $32.94 $4,733 - $7,971	242 New	242 $5,000

144

57.7M

137K

111K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $252M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.